Literature DB >> 11405806

Early electrodiagnostic findings in Guillain-Barré syndrome.

P H Gordon1, A J Wilbourn.   

Abstract

CONTEXT: Guillain-Barré syndrome (GBS) is the foremost cause of acute, generalized, peripheral neuropathic weakness. Although nerve conduction studies are a diagnostic aid, the characteristic electrical changes may not evolve for several weeks. Early diagnosis of GBS is important, however, because early treatment has been shown to improve outcome.
OBJECTIVES: To describe the electrodiagnostic abnormalities detectable in the first week of GBS, to determine if there are early patterns suggestive of GBS, and to identify the percentage of patients whose condition can be diagnosed with reasonable certainty in the first week. DESIGN AND
SETTING: We retrospectively reviewed the medical records of all patients admitted to the Cleveland Clinic Foundation, Cleveland, Ohio, having the discharge diagnosis GBS during the past 16 years. Patients who underwent nerve conduction studies within 7 days of muscle weakness were selected for this study.
RESULTS: The H reflex was absent in 30 (97%) of 31 patients. Nineteen patients (61%) had low-amplitude or absent sensory nerve action potential (SNAP) in the upper extremity. Fifteen patients (48%) overall, including 21 (67%) of the 31 patients, including 14 (67%) of the 21 patients younger than 60 years, had an abnormal upper extremity SNAP combined with a normal sural SNAP. Other findings included an abnormal F wave (25 patients [84%]), reduced compound muscle action potential amplitude (22 patients [71%]), prolonged distal latency (20 patients [65%]), temporal dispersion (18 patients [58%]), slowed motor conduction velocity (16 patients [52%]), and motor conduction block (4 patients [13%]). Definite diagnosis was possible in 17 patients (55%), but not commonly until the fifth day.
CONCLUSIONS: The H reflex is the most sensitive test for early GBS. Upper extremity SNAPs are also frequently abnormal in early GBS. Absent H response, abnormal F wave, and abnormal upper extremity SNAP combined with a normal sural SNAP are characteristic of early GBS. If multiple nerves are tested, definite diagnosis is possible in half the patients, but not until the fifth day after the onset of symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11405806     DOI: 10.1001/archneur.58.6.913

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  28 in total

1.  Neurological complications of biologic therapy in psoriasis: a review.

Authors:  Mark Bechtel; Catherine Sanders; Ann Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2009-11

2.  Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.

Authors:  Takafumi Hosokawa; Hideto Nakajima; Kiichi Unoda; Kazushi Yamane; Yoshimitsu Doi; Shimon Ishida; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2016-06-08       Impact factor: 4.849

3.  Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics.

Authors:  Angelika Derksen; Christian Ritter; Parveen Athar; Bernd C Kieseier; Pedro Mancias; Hans-Peter Hartung; Kazim A Sheikh; Helmar C Lehmann
Journal:  Muscle Nerve       Date:  2014-09-24       Impact factor: 3.217

Review 4.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

5.  Acute Motor Conduction Block Neuropathy: Another Distinct Variant of Guillain-Barre Syndrome.

Authors:  Nilüfer Erdoğmuş Ince; M Fevzi Öztekin; Neşe Öztekin
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

Review 6.  Retraining Reflexes: Clinical Translation of Spinal Reflex Operant Conditioning.

Authors:  Amir Eftekhar; James J S Norton; Christine M McDonough; Jonathan R Wolpaw
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

7.  Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: A case report.

Authors:  Mumtaz A Niazi; Ashaur Azhar; Kashif Tufail; Eyob L Feyssa; Stephen F Penny; Marlene McGregory; Victor Araya; Jorge A Ortiz
Journal:  World J Hepatol       Date:  2010-04-27

8.  A case of Guillain-Barré syndrome (GBS) presenting with acute urinary retention and T6 sensory level.

Authors:  Ching Soong Khoo; Alyaa Hassan Ali; Rabani Remli; Hui Jan Tan
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

Review 9.  Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Authors:  Johannes Brettschneider; Axel Petzold; Sigurd Süssmuth; Hayrettin Tumani
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

10.  Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.

Authors:  Julia Wanschitz; Rainer Ehling; Wolfgang N Löscher; Betinna Künz; Florian Deisenhammer; Jens Kuhle; Herbert Budka; Markus Reindl; Thomas Berger
Journal:  J Neurol       Date:  2008-07-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.